Follow-up strategies for de-escalating multiple sclerosis treatment
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests different ways of monitoring people with relapsing-remitting MS who are reducing or stopping their medication. It aims to find the safest follow-up approach and may help guide future treatment decisions for those with stable disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have relapsing-remitting MS (RRMS) as diagnosed by standard criteria.
- You are either scaling down a high-efficacy treatment or stopping a lower-efficacy disease-modifying therapy (DMT).
- You are able to use a smartphone (required for the main study site).
- Your EDSS score (disability level) must be less than 7.0.
- You have not had an MS relapse or received IV steroids or immunoadsorption in the last 6 weeks.
- You do not have primary or secondary progressive MS, and no condition that would make it hard to follow the study (like severe memory problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a smartphone app can help monitor spasticity (muscle tightness or stiffness) in people with multiple sclerosis. If you have MS and spasticity that needs treatment, using your own smartphone might help track your health.
This study uses smartphone apps to track your MS symptoms and activity over time. The goal is to see if these digital tools can detect when your disease is active or progressing, which could help improve monitoring in the future.
This study follows people with multiple sclerosis over time using a smartphone app and clinic visits. It aims to better understand the disease and improve care.
This study looks at how information from a brain/spinal MRI and a smartphone relates to walking and daily function in people with multiple sclerosis (MS). It may help researchers understand what signals predict changes over time.
This study tests a new digital tool designed to help monitor and manage multiple sclerosis (MS). You'll use the tool as part of regular check-ins, and researchers will see if it helps track your condition better over time.
This study tests a smartphone app called MS Copilot Boost that aims to help reduce fatigue in people with MS. You will use the app along with wearing a small wrist device, and we compare it with usual care to see if it improves fatigue.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.